FIELD: medicine.
SUBSTANCE: presented group of inventions refers to medicine, particularly oncology and molecular biology. Disclosed is a method of producing data applicable for prediction of overweight, obesity and/or complications thereof, which involves detecting and/or quantifying mRNA levels of Lrp11, Gls and Ubash3b genes in a biological sample recovered from a subject, wherein increase of Lrp11, Gls and Ubash3b gene expression relative to control reference value is associated with unfavourable prognosis. Disclosed is an in vitro method for prediction of overweight, obesity and/or complications thereof in a subject, an in vitro method for developing an individual treated leptin treatment or a leptin-containing composition and the in vitro method for assessing the clinical effectiveness using leptin or a leptin-containing composition, as well as kits for their implementation.
EFFECT: presented group of inventions enables to develop and implement effective treatment involving assessing the consumption of leptin.
62 cl, 1 dwg, 7 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF RISK OF METABOLIC COMPLICATIONS OF OBESITY IN CHILDREN | 2024 |
|
RU2821562C1 |
MEDICAL PREDICTION AND PREDICTION OF TREATMENT RESULTS USING ACTIVITY OF MULTIPLE CELL SIGNALING PATHWAYS | 2014 |
|
RU2718647C2 |
COMPOSITIONS AND METHODS HAVING EFFECT ON SATURATION, LIPID METABOLISM AND FAT INTAKE | 2009 |
|
RU2546291C2 |
METHODS FOR INDUCING AND PROLONGING SATURATION, REDUCING VOLUME AND ABSORPTION OF FOOD, CONTROLLING WEIGHT AND STIMULATING WEIGHT LOSS | 2017 |
|
RU2766585C2 |
PHARMACEUTICAL AND NUTRITIONAL COMPOSITIONS FOR INDUCING SATIETY AND PROLONGING THE SATIETY SENSATION IN THE SUBJECTS IN NEED THEREOF | 2015 |
|
RU2717018C2 |
METHOD AND DEVICE FOR in vitro ANALYSIS OF GENE mRNA INVOLVED IN DEVELOPMENT OF HEMATOLOGIC NEOPLASIAS | 2006 |
|
RU2426786C2 |
TREATING SIRTIUN 1 (SIRT1)-RELATED DISEASES BY INHIBITON OF NATURAL ANTISENSE TRANSCRIPT | 2009 |
|
RU2551234C2 |
PREVENTION/REDUCTION OF ISCHEMIA-RELATED DAMAGES | 2018 |
|
RU2768889C2 |
DIACYLGLYCERIN-ACYLTRANSFERASE ANALYSIS | 2005 |
|
RU2415946C2 |
MONOCLONAL ANTIBODIES AGAINST CLAUDIN 1 FOR PREVENTION AND TREATMENT OF HEPATOCELLULAR CARCINOMA | 2016 |
|
RU2770021C2 |
Authors
Dates
2019-09-12—Published
2015-03-24—Filed